GCM2 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the GCM2 (Glial Cells Missing Homolog 2) protein, a transcription factor primarily involved in the regulation of calcium-sensing receptors and parathyroid gland development. The GCM2 protein belongs to the GCM (Glial Cells Missing) family of transcription factors, which are known to play essential roles in cell differentiation and development in various biological systems. GCM2, in particular, functions by binding to specific DNA sequences and promoting or repressing the transcription of target genes, often those involved in calcium homeostasis and parathyroid activity. Inhibitors of GCM2 act by either directly binding to the GCM2 protein, altering its conformation and reducing its ability to bind to DNA, or by interfering with its interaction with co-factors or other proteins that assist in its transcriptional activity.
The mechanisms of GCM2 inhibition are of interest due to the crucial roles this protein plays in cellular development and gene expression regulation. Structural studies of GCM2 inhibitors have revealed that these molecules can vary significantly in their chemical makeup, often including functional groups that enable specific binding affinity to the GCM2 protein or its active domains. These inhibitors can be designed to exploit the unique structural features of GCM2, including its zinc-binding motif and GCM DNA-binding domain. This selective inhibition can result in the modulation of GCM2's downstream signaling pathways, impacting the expression of genes controlled by this transcription factor. Continued research into the chemistry and structure-function relationships of GCM2 inhibitors provides deeper insights into their role in regulating key biological processes, particularly those related to gene expression and cellular homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A could downregulate GCM2 by promoting a closed chromatin conformation, hindering the binding of transcriptional machinery to the GCM2 promoter. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid (Vorinostat) may decrease GCM2 transcription by inhibiting histone deacetylases, leading to increased histone acetylation and suppression of gene activity. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic Acid might reduce GCM2 expression by causing hyperacetylation of histones at the GCM2 gene locus, thereby obstructing transcriptional activation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could lead to a decrease in GCM2 expression by inducing DNA demethylation at the GCM2 promoter, thereby attenuating transcription initiation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-Aza-2′-Deoxycytidine (Decitabine) may downregulate GCM2 by reducing methylation levels at the GCM2 gene promoter, which is often associated with transcriptional silencing. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin might suppress the transcription of GCM2 by inhibiting the mTOR pathway, which could lead to decreased activity of transcription factors that promote GCM2 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY2 94002 could decrease GCM2 expression through the inhibition of the PI3K/Akt pathway, which may be necessary for the transcriptional activation of the GCM2 gene. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin may downregulate GCM2 by perturbing calcium stores, which could trigger cellular stress responses that lead to the repression of GCM2 transcription. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $41.00 $143.00 | 27 | |
Bicalutamide could lead to reduced GCM2 expression by antagonizing androgen receptors, which may play a role in the hormonal control of the GCM2 gene expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone may decrease the expression of GCM2 by activating glucocorticoid receptors that interact with promoter regions of the GCM2 gene, leading to transcriptional repression. | ||||||